More recent studies have shown that, specifically, PMCA2 remodels [Ca2+]i in breast cancer cells to facilitate continued HER2 biochemical signalling and PMCA2 knock out inhibits the formation of tumours in vivo [234]. The gene discussed is ATP2B2; the disease is breast carcinoma.